Robert J. Motzer, David A. Braun, Thomas Powles, Howard Gurney, Lawrence Fong, Daniel J. George, Naomi Balzer Haas, David F. McDermott, Brian M. Shuch, Robert Meehan, Tracey Posadas, Sterling Wu, Aymen Elfiky, Toni K. Choueiri. "INTerpath-004: A phase 2, randomized, double-blind study of adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) or placebo for renal cell carcinoma (RCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps610